Adverum Bio Ownership | Who Owns Adverum Bio?
Adverum Bio Ownership Summary
Adverum Bio is owned by 64.26% institutional investors, 13.04% insiders, and 22.69% retail investors. Bml capital management is the largest institutional shareholder, holding 14.55% of ADVM shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 5.45% of its assets in Adverum Bio shares.
ADVM Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Adverum Bio | 64.26% | 13.04% | 22.69% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 307.00% | 11.11% | -218.12% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Bml capital management | 3.06M | 14.55% | $6.57M |
Tcg crossover management | 1.80M | 8.55% | $3.86M |
Frazier life sciences management | 1.07M | 5.09% | $2.30M |
Versant venture management | 506.82K | 2.43% | $2.37M |
Blackrock funding, inc. /de | 414.49K | 1.97% | $891.14K |
Pale fire capital se | 358.72K | 1.71% | $771.26K |
Soleus capital management | 287.25K | 1.37% | $617.58K |
Regeneron pharmaceuticals | 180.91K | 0.86% | $388.95K |
Waverly advisors | 160.58K | 0.76% | $345.24K |
Readystate asset management lp | 67.60K | 0.32% | $145.34K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Bml capital management | 3.06M | 4.97% | $6.57M |
Versant venture management | 506.82K | 2.73% | $2.37M |
Tcg crossover management | 1.80M | 0.44% | $3.86M |
Frazier life sciences management | 1.07M | 0.09% | $2.30M |
Pale fire capital se | 358.72K | 0.08% | $771.26K |
Soleus capital management | 287.25K | 0.04% | $617.58K |
Regeneron pharmaceuticals | 180.91K | 0.03% | $388.95K |
Quinn opportunity partners | 41.42K | 0.01% | $89.05K |
Point72 asia (singapore) pte. | 14.58K | 0.01% | $31.35K |
Readystate asset management lp | 67.60K | 0.00% | $145.34K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bml capital management | 3.06M | 4.97% | 315.21K |
Readystate asset management lp | 67.60K | 0.00% | 67.60K |
Marshall wace, llp | 49.63K | 0.00% | 49.63K |
Qube research | 30.68K | 0.00% | 30.68K |
Hrt financial lp | 30.63K | 0.00% | 30.63K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Franklin resources | - | - | -1.76M |
Blackrock funding, inc. /de | 414.49K | - | -1.01M |
Invesco | - | - | -49.83K |
Bank of new york mellon | - | - | -49.32K |
Charles schwab investment management | - | - | -49.02K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Readystate asset management lp | 67.60K | 0.00% | 67.60K | $145.34K |
Qube research | 30.68K | 0.00% | 30.68K | $65.96K |
Hrt financial lp | 30.63K | 0.00% | 30.63K | $65.00K |
Xtx topco | 29.75K | 0.00% | 29.75K | $63.97K |
Y-intercept (hong kong) | 21.12K | 0.00% | 21.12K | $45.41K |
Sold Out
Holder | Change |
---|---|
Frazier financial advisors | -1.00 |
Eversource wealth advisors | -7.00 |
Gamma investing | -47.00 |
Rothschild investment | -100.00 |
Group one trading | -292.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 57 | -18.57% | 13,501,908 | -11.69% | 64 | 1.21% | 27 | -6.90% | 19 | -17.39% |
Mar 31, 2025 | 71 | 2.90% | 15,830,377 | -0.28% | 75 | 1.31% | 29 | -19.44% | 23 | 109.09% |
Dec 31, 2024 | 1 | - | 506,821 | - | 2 | 41.19% | - | - | - | - |
Sep 30, 2024 | 1 | -50.00% | 506,821 | -79.85% | 2 | 1.04% | - | - | - | -100.00% |
Jun 30, 2024 | 2 | -33.33% | 2,515,161 | -29.83% | 15 | 1.22% | - | -100.00% | 1 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Franklin Biotechnology Discv A(acc)USD | 1.14M | 5.45% | - |
Franklin Biotechnology Discovery A | 624.74K | 3.00% | - |
Vanguard US Total Market Shares ETF | 586.25K | 2.82% | - |
Vanguard Total Stock Mkt Idx Inv | 573.71K | 2.73% | -12.54K |
Fidelity Small Cap Index | 215.28K | 1.03% | -757.00 |
Vanguard Institutional Extnd Mkt Idx Tr | 196.33K | 0.94% | -89.46K |
iShares Russell 2000 Value ETF | 181.86K | 0.87% | - |
CREF Stock R1 | 140.59K | 0.68% | -93.24K |
Vanguard Russell 2000 ETF | 103.78K | 0.50% | 954.00 |
State St Russell Sm/Mid Cp® Indx NL Cl C | 94.53K | 0.45% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 15, 2025 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | $5.92K |
May 15, 2025 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | $1.85K |
May 15, 2025 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | $18.25K |
Mar 27, 2025 | Leonard Braden Michael | - | Buy | $86.09K |
Apr 22, 2025 | Leonard Braden Michael | - | Buy | $900.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 3 | 3 |
2025 Q1 | 10 | - |
2024 Q3 | 3 | - |
2024 Q2 | - | - |
2024 Q1 | 2 | - |
ADVM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools